Speaker(s):
Hannah Spence PharmD, PGY1 resident, Geisinger - has nothing to disclose.
Moderator(s):
Christopher J DeFrancesco PharmD, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
Define adaptogens and their proposed mechanism of improving health.
Identify safety concerns and side effects of Ashwagandha.
Evaluate clinical evidence of the efficacy of Ashwagandha.
Review quality concerns of herbal supplements in the United States.
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH, Anil Singh MD, Roop Parlapalli, MD, FHM, FACP, Mary Ellen Berry PA-C, and Carlena Miller CRNP have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
- 0.50 AAPA Category I CME
- 0.50 ACPE
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Participation Credit

Facebook
X
LinkedIn
Forward